MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 98 filers reported holding MAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,516,199 | -36.4% | 2,409,038 | -6.5% | 0.09% | -30.0% |
| Q2 2023 | $11,825,033 | +3.9% | 2,576,260 | +12.1% | 0.13% | +0.8% |
| Q1 2023 | $11,380,416 | -7.7% | 2,299,074 | +1.8% | 0.13% | -12.2% |
| Q4 2022 | $12,329,947 | -14.9% | 2,258,232 | +1.4% | 0.15% | -17.4% |
| Q3 2022 | $14,483,000 | +42.1% | 2,228,099 | +3.4% | 0.18% | +52.1% |
| Q2 2022 | $10,190,000 | +12.8% | 2,154,237 | +66.6% | 0.12% | +48.1% |
| Q1 2022 | $9,036,000 | -27.4% | 1,292,713 | +5.8% | 0.08% | -21.0% |
| Q4 2021 | $12,450,000 | -13.4% | 1,221,750 | +3.7% | 0.10% | -11.5% |
| Q3 2021 | $14,382,000 | – | 1,177,924 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 480,900 | $3,361,000 | 4.94% |
| Casdin Capital, LLC | 13,971,334 | $97,660,000 | 4.38% |
| Vitruvian Partners LLP | 4,385,670 | $30,656,000 | 3.25% |
| RIVER GLOBAL INVESTORS LLP | 2,100,000 | $14,849,000 | 1.95% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $1,258,000 | 1.52% |
| Pier Capital, LLC | 1,017,753 | $7,114,000 | 0.91% |
| First Light Asset Management, LLC | 1,321,406 | $9,237,000 | 0.82% |
| Montanaro Asset Management Ltd | 929,000 | $6,557,000 | 0.81% |
| Nicholas Investment Partners, LP | 776,963 | $5,431,000 | 0.39% |
| Bleichroeder LP | 250,000 | $1,764,000 | 0.31% |